ICUI FINANCIAL STATEMENTS

ICU Medical Inc — balance sheet, income statement and cash flow trends

ICUIICU Medical Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue2.2 B $-10.9%

Gross Profit784.2 M $-7.7%

Operating Income80.2 M $+20.6%

EBITDA262.7 M $-5.7%

Net Income46.3 M $—

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ICUI	-10.9%	36.4%	12.2%	2.1%
ANN	11.4%	41.9%	15.2%	6.7%
FPH	4.8%	64.2%	34.9%	20.0%
RMD	10.5%	61.2%	39.1%	27.4%
EL	7.5%	60.6%	23.0%	8.1%
CTEC	6.8%	55.8%	25.3%	7.2%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ICUI	-10.9%	36.4%	12.2%	2.1%
WRBY	12.0%	53.4%	6.1%	0.2%
MMSI	11.2%	48.7%	22.6%	9.0%
NVST	12.1%	55.1%	12.3%	2.4%
TFX	-6.6%	53.3%	-3.1%	-35.9%
LMAT	13.3%	72.4%	37.6%	24.3%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity2.1 B $53%
Current Liabilities517.9 M $13%
Long-term Liabilities1.4 B $34%

Key Figures

YoY change

Total Assets4 B $-4.1%

Total Liabilities1.9 B $-13.4%

Total Equity2.1 B $+6.3%

Cash & ST Investments288.3 M $-0.5%

Total Debt1.3 B $-16.2%

Net Debt1.1 B $-19.7%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ICUI	2.30	63.5%	4.01	52.6%
ANN	2.36	46.2%	2.10	59.3%
FPH	2.31	6.9%	-0.39	74.1%
RMD	3.01	13.0%	-0.38	73.9%
EL	0.99	37.0%	1.66	60.9%
CTEC	1.53	100.0%	2.33	40.1%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ICUI	2.30	63.5%	4.01	52.6%
WRBY	2.33	63.2%	-0.94	51.0%
MMSI	5.08	50.5%	0.95	59.8%
NVST	2.44	51.6%	1.46	55.2%
TFX	2.55	87.1%	-26.86	45.5%
LMAT	14.32	46.7%	-1.84	64.6%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow167.4 M $-20.1%

Capital Expenditures87 M $+15.7%

Free Cash Flow80.4 M $-40.2%

Dividends Paid——

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ICUI	7.8%	3.7%	4.0%	361.3%
ANN	11.7%	8.3%	3.4%	173.5%
FPH	28.4%	21.0%	7.4%	141.7%
RMD	34.2%	31.7%	2.5%	124.8%
EL	18.6%	13.2%	5.4%	228.6%
CTEC	19.1%	14.1%	4.9%	265.8%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ICUI	7.8%	3.7%	4.0%	361.3%
WRBY	11.9%	4.4%	7.5%	7,870.6%
MMSI	19.3%	16.7%	5.3%	213.5%
NVST	9.7%	7.8%	1.8%	401.9%
TFX	11.2%	8.9%	3.0%	-31.2%
LMAT	34.1%	30.9%	3.2%	139.9%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ICUI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.